STOCK TITAN
  1. Home
  2. Sec-filings
  3. XGN
  4. [EFFECT] Exagen Inc. SEC Filing

[EFFECT] Exagen Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 2, 2025 4:01 P.M.
Form: S-3
CIK: 0001274737
Company Name: EXAGEN INC.
File Number: 333-288199

Source: View Original Filing on SEC EDGAR

Stock XGN logo
Exagen Inc.

NASDAQ:XGN

XGN Rankings

#4967 Ranked by Market Cap
N/A Ranked by Dividends

XGN Latest News

Jan 11, 2026
Exagen Inc. Announces Select Preliminary 2025 Financial Results
Nov 11, 2025
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
Nov 4, 2025
Exagen Inc. Reports Strong Q3 2025 Results
Oct 23, 2025
Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence
Oct 21, 2025
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025

XGN Latest SEC Filings

Jan 12, 2026
[8-K] EXAGEN INC. Reports Material Event
Nov 4, 2025
[10-Q] EXAGEN INC. Quarterly Earnings Report
Nov 4, 2025
[8-K] EXAGEN INC. Reports Material Event
Oct 20, 2025
[Form 4] EXAGEN INC. Insider Trading Activity
Sep 4, 2025
[Form 4] Exagen Inc. Insider Trading Activity

XGN Stock Data

107.20M
15.85M
15.29%
57.82%
2.99%
Diagnostics & Research
Services-medical Laboratories
Link
United States
VISTA